E. Ruoslahti (2002)
Specialization of tumour vasculatureNature Reviews Cancer, 2
K. Sugahara, T. Teesalu, P. Karmali, V. Kotamraju, L. Agemy, O. Girard, D. Hanahan, R. Mattrey, E. Ruoslahti (2009)
Tissue-penetrating delivery of compounds and nanoparticles into tumors.Cancer cell, 16 6
J. Hoffman, E. Giraudo, Mallika Singh, Lianglin Zhang, M. Inoue, K. Porkka, D. Hanahan, E. Ruoslahti (2003)
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.Cancer cell, 4 5
E. Koivunen, B. Wang, E. Ruoslahti (1995)
Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed IntegrinsBio/Technology, 13
Lisette Acevedo, S. Barillas, S. Weis, J. Göthert, D. Cheresh (2008)
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor.Blood, 111 5
B. Fendly, M. Winget, R. Hudziak, M. Lipari, M. Napier, A. Ullrich (1990)
Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product.Cancer research, 50 5
See supporting material on Science Online for methods and additional data. Statistical analyses are summarized in table S1
T. Teesalu, K. Sugahara, V. Kotamraju, E. Ruoslahti (2009)
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetrationProceedings of the National Academy of Sciences, 106
O. Arola, A. Saraste, Kari Pulkki, M. Kallajoki, M. Parvinen, L. Voipio‐Pulkki (2000)
Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.Cancer research, 60 7
D. Tagle, F. Collins (1992)
An optimized Alu-PCR primer pair for human-specific amplification of YACs and somatic cell hybrids.Human molecular genetics, 1 2
C. Pellet-Many, P. Frankel, H. Jia, I. Zachary (2008)
Neuropilins: structure, function and role in disease.The Biochemical journal, 411 2
P. Carter, L. Presta, C. Gorman, J. Ridgway, D. Henner, Wai Wong, A. Rowland, C. Kotts, M. Carver, H. Shepard (1992)
Humanization of an anti-p185HER2 antibody for human cancer therapy.Proceedings of the National Academy of Sciences of the United States of America, 89
R. Petrioli, A. Fiaschi, E. Francini, A. Pascucci, G. Francini (2008)
The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer.Cancer treatment reviews, 34 8
Fan Yuan, M. Dellian, D. Fukumura, M. Leunig, D. Berk, V. Torchilin, R. Jain (1995)
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.Cancer research, 55 17
Eric Murphy, B. Majeti, Leo Barnes, M. Makale, S. Weis, Kimberly Lutu-Fuga, W. Wrasidlo, D. Cheresh (2008)
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasisProceedings of the National Academy of Sciences, 105
Ji-Ho Park, G. Maltzahn, Lianglin Zhang, A. Derfus, D. Simberg, T. Harris, E. Ruoslahti, S. Bhatia, M. Sailor (2009)
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting.Small, 5 6
Pirjo Laakkonen, K. Porkka, J. Hoffman, E. Ruoslahti (2002)
A tumor-homing peptide with a targeting specificity related to lymphatic vesselsNature Medicine, 8
K. Porkka, Pirjo Laakkonen, J. Hoffman, Michele Bernasconi, E. Ruoslahti (2002)
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivoProceedings of the National Academy of Sciences of the United States of America, 99
J. Joyce, Pirjo Laakkonen, Michele Bernasconi, G. Bergers, E. Ruoslahti, D. Hanahan (2003)
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis.Cancer cell, 4 5
H. Maeda, Jun Fang, T. Inutsuka, Y. Kitamoto (2003)
Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications.International immunopharmacology, 3 3
J. Desgrosellier, D. Cheresh (2010)
Integrins in cancer: biological implications and therapeutic opportunitiesNature Reviews Cancer, 10
Tina Primeau, N. Myers, Y. Yu, L. Lybarger, Xiaoli Wang, S. Truscott, T. Hansen, J. Connolly (2005)
Applications of major histocompatibility complex class I molecules expressed as single chainsImmunologic Research, 32
A. Minchinton, I. Tannock (2006)
Drug penetration in solid tumoursNature Reviews Cancer, 6
H. Jia, Azadeh Bagherzadeh, B. Hartzoulakis, Ashley Jarvis, M. Löhr, Shaheda Shaikh, Rehan Aqil, Lili Cheng, Michelle Tickner, D. Esposito, Richard Harris, P. Driscoll, D. Selwood, I. Zachary (2006)
Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling*Journal of Biological Chemistry, 281
T. Hambley, W. Hait (2009)
Is anticancer drug development heading in the right direction?Cancer research, 69 4
T. Murohara, J. Horowitz, Marcy Silver, Y. Tsurumi, Dongfen Chen, A. Sullivan, J. Isner (1998)
Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.Circulation, 97 1
K. Black, N. Ningaraj (2004)
Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.Cancer control : journal of the Moffitt Cancer Center, 11 3
W. Monsky, D. Fukumura, T. Gohongi, Marek Ancukiewcz, H. Weich, V. Torchilin, F. Yuan, R. Jain (1999)
Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.Cancer research, 59 16
A. Miles, E. Miles (1952)
Vascular reactions to histamine, histamine‐liberator and leukotaxine in the skin of guinea‐pigsThe Journal of Physiology, 118
P. Karmali, V. Kotamraju, M. Kastantin, Matthew Black, D. Missirlis, M. Tirrell, E. Ruoslahti (2009)
Targeting of albumin-embedded paclitaxel nanoparticles to tumors.Nanomedicine : nanotechnology, biology, and medicine, 5 1
E. Ruoslahti, S. Bhatia, M. Sailor (2010)
Targeting of drugs and nanoparticles to tumorsThe Journal of Cell Biology, 188
F. Pastorino, D. Paolo, F. Piccardi, B. Nico, D. Ribatti, A. Daga, G. Baio, C. Neumaier, C. Brignole, M. Loi, D. Marimpietri, G. Pagnan, M. Cilli, E. Lepekhin, S. Garde, R. Longhi, A. Corti, T. Allen, Jinzi Wu, M. Ponzoni (2008)
Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal DoxorubicinClinical Cancer Research, 14
E. Koivunen, D. Gay, E. Ruoslahti (1993)
Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library.The Journal of biological chemistry, 268 27
Science – Unpaywall
Published: May 21, 2010
Access the full text.
Sign up today, get DeepDyve free for 14 days.